Logo
IMMUNOFLUORESCENCE ANALYZER MARKET ANALYSIS
  2. / Market Insights
  3. Immunofluorescence Analyzer Market Analysis
all report title image

IMMUNOFLUORESCENCE ANALYZER MARKET ANALYSIS

Immunofluorescence Analyzer Market, by Product Type (Enzyme Linked Fluorescent Immunoassay, Chemiluminescence Immunoassay, Radioimmunoassay, and Enzyme Linked Immunosorbent Assay), by End User, and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Dec 2024
  • Code : CMI1794
  • Formats :
      Excel and PDF
  • Industry : Clinical Diagnostic

Market News

Key Development  

  • In 2018, F. Hoffmann-La Roche Ag launched ventana pan-trk (epr17341) assay, which is an automated in vitro diagnostic immunohistochemistry assay used to detect tropomyosin receptor kinase proteins in cancer.
  • In 2017, Abbott received FDA approval for its Alinity ci-series instruments. The portfolio includes immunoassay diagnostics, clinical chemistry, blood and plasma screening, point-of-care, hematology, and AlinIQ holistic suite, which provides professional services with informatics and process analysis.
  • In 2017, Siemens Healthineers launched the Atellica solution, which is an immunofluorescence analyzer solution.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.